Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
Source: SeekingAlpha
2026-03-06 13:44:14 ET
More on IQVIA, Medpace
- IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder
- IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
- Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
- Charles River announces divestitures, updates guidance
- Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts
Read the full article on Seeking Alpha
For further details see:
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
Pacific Biosciences of California Inc.
NASDAQ: PACB
PACB Trading
-2.83% G/L:
$1.375 Last:
1,981,899 Volume:
$1.38 Open:
PACB Latest News
March 05, 2026 08:30:00 am
PacBio Announces the Appointment of Chris Gibson to the Board of Directors
February 24, 2026 09:05:00 am
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
February 18, 2026 04:05:00 pm
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
PACB Stock Data
$549,471,524
294,359,745
0.64%
78
N/A
Biotechnology & Life Sciences
Healthcare
US
Menlo Park
